-transparent.png){kind=logo}
Novel acyclic nucleoside phosphonates with a pyrimidine base preferentially containing an amino group at C-2 and C-4 and a 2-(phosphonomethoxy)ethoxy or (R)-2-(phosphonomethoxy)propoxy group at C-6 selectively inhibit the replication of wild-type and lamivudine-resistant hepatitis B viruses. The activity of the most potent compounds was comparable to that of adefovir.
Related Publications
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
July 2022,
Journal of medicinal chemistry,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
January 2009,
Zeitschrift fur Naturforschung. C, Journal of biosciences,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
January 1998,
Advances in experimental medicine and biology,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
September 2010,
Nucleosides, nucleotides & nucleic acids,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
December 1998,
Antimicrobial agents and chemotherapy,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
November 2002,
Bioorganic & medicinal chemistry letters,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
January 1991,
International journal of immunopharmacology,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
March 2008,
World journal of gastroenterology,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
July 1991,
Biochemical and biophysical research communications,
C Ying, and
A Holy, and
D Hocková, and
Z Havlas, and
E De Clercq, and
J Neyts
May 2010,
Beilstein journal of organic chemistry,
